Michelon Francois Roger 4
4 · ENDRA Life Sciences Inc. · Filed Feb 1, 2023
Insider Transaction Report
Form 4
Michelon Francois Roger
DirectorChief Executive Officer
Transactions
- Award
Stock Options
2023-01-30+69,531→ 69,531 totalExercise: $4.02Exp: 2033-01-30→ Common Stock (69,531 underlying)
Footnotes (1)
- [F1]This stock option grant becomes exercisable in three equal annual installments beginning January 30, 2024.